Artemis Investment Management’s Teladoc Health TDOC Stock Holding History

Artemis Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-71,168	Closed	-$15.6M	–	298
2020 Q3	$15.6M	Buy	71,168 +692	+1%	+$147K	0.2%	145
2020 Q2	$13.5M	Sell	70,476 -27,287	-28%	-$4.78M	0.18%	135
2020 Q1	$14.8M	Sell	97,763 -940	-1%	-$109K	0.03%	99
2019 Q4	$8.06M	Sell	98,703 -29,116	-23%	-$2.22M	0.1%	178
2019 Q3	$8.44M	Sell	127,819 -24,081	-16%	-$1.58M	0.12%	183
2019 Q2	$9.8M	Buy	151,900 +7,147	+5%	+$417K	0.12%	194
2019 Q1	$8.05M	Sell	144,753 -3,078	-2%	-$188K	0.09%	215
2018 Q4	$7.33M	Sell	147,831 -85,045	-37%	-$5.2M	0.1%	192
2018 Q3	$20.1M	Buy	+232,876	New	+$16.6M	0.22%	116

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artemis Investment Management's TDOC Position: Q4 2020 in Review

Artemis Investment Management sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 71,168 shares — an estimated $15.6M sold.

Artemis Investment Management first reported a position in TDOC in Q3 2018 and held it in 9 quarters. The position peaked at $20.1M in Q3 2018. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

Artemis Investment Management reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
Artemis Investment Management sold 71,168 Teladoc Health shares in Q4 2020, an estimated $15.6M.
Artemis Investment Management first reported a position in Teladoc Health in Q3 2018 and held it in 9 quarters.
Artemis Investment Management's Teladoc Health position peaked at $20.1M in Q3 2018.
901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Artemis Investment Management's 13F filing for Q4 2020, filed 26 Jan 2021.